Inventor · disambiguated record
Ralph B. Arlinghaus
Also filed as: ARLINGHAUS RALPH · ARLINGHAUS RALPH B
16 granted patents·5 pending applications·391 citations·filing 1989–2015
95Inventor score
Top patents by PatentIndex Score
21 records- 0193US7923548B2Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1UNIV TEXAS·Filed 2007·Granted Apr 12, 2011·9 cites·24 claims
- 0289US5128319AProphylaxis and therapy of acquired immunodeficiency syndromeUNIV TEXAS·Filed 1989·Granted Jul 7, 1992·80 cites·42 claims
- 0387US8338366B2Bioactive FUS1 peptides and nanoparticle-polypeptide complexesLIN JACKI·Filed 2006·Granted Dec 25, 2012·13 cites·31 claims
- 0485US7220853B2Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1UNIV TEXAS·Filed 2002·Granted May 22, 2007·13 cites·5 claims
- 0579US6265539B1Prophylaxis and therapy of acquired immunodeficiency syndromeUNIV TEXAS·Filed 1992·Granted Jul 24, 2001·44 cites·18 claims
- 0679US5369008AMethods for the detection of BCR-ABL and abnormal ABL proteins in leukemia patientsUNIV TEXAS·Filed 1993·Granted Nov 29, 1994·57 cites·32 claims
- 0778US6107457ABcr-Abl directed compositions and uses for inhibiting Philadelphia chromosome stimulated cell growthUNIV TEXAS·Filed 1995·Granted Aug 22, 2000·36 cites·21 claims
- 0874US7306804B2HIV-specific T-cell inductionUNIV TEXAS·Filed 2003·Granted Dec 11, 2007·12 cites·25 claims
- 0974US6656471B1HIV-specific T-cell inductionUNIV TEXAS·Filed 1999·Granted Dec 2, 2003·38 cites·25 claims
- 1073US8859727B2Bioactive FUS1 peptides and nanoparticle-polypeptide complexesUNIV TEXAS·Filed 2012·Granted Oct 14, 2014·2 cites·18 claims
- 1163US5603933ACD4 peptides for binding to viral envelope proteinsUNIV TEXAS·Filed 1993·Granted Feb 18, 1997·35 cites·10 claims
- 1259US7319000B1Compositions and methods for eliciting immune or anti-infective responsesUNIV TEXAS·Filed 1997·Granted Jan 15, 2008·15 cites·14 claims
- 1357US7309692B1Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1UNIV TEXAS·Filed 1996·Granted Dec 18, 2007·10 cites·11 claims
- 1456US2002151678A1Prophylaxis and therapy of acquired immunodeficiency syndromeUNIV TEXAS·Filed 2001·Application pending·0 cites
- 1549US6210873B1Methods and compositions for the priming of specific cytotoxic T-lymphocyte responseUNIV TEXAS·Filed 1991·Granted Apr 3, 2001·16 cites·14 claims
- 1649US2004022772A1Bcr-Abl directed compositions and uses for inhibiting Philadelphia chromosome stimulated cell growthFiled 2003·Application pending·0 cites
- 1745US6537804B1BCR-ABL directed compositions and uses for inhibiting Philadelphia chromesome stimulated cell growthUNIV TEXAS·Filed 1996·Granted Mar 25, 2003·3 cites·22 claims
- 1841US5126399AMethods and compositions for the preparation and use of site-directed immunologic reagentsUNIV TEXAS·Filed 1989·Granted Jun 30, 1992·8 cites·9 claims
- 1941US2008274104A1Targeting a Secreted Pro-Apoptotic Factor for Cancer TherapeuticsARLINGHAUS RALPH B·Filed 2006·Application pending·0 cites
- 2036US2017088623A1Prophylaxis Against Cancer MetastasisALT ECKHARD U·Filed 2015·Application pending·0 cites
- 2134US2012219561A1Prophylaxis Against Cancer MetastasisALT ECKHARD U·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ralph B. Arlinghaus files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →